Cargando…

Outcomes of bortezomib combination chemotherapies in autologous stem cell transplantation-ineligible patients with AL amyloidosis

BACKGROUND: Treatment protocols for light chain (AL) amyloidosis have been derived from myeloma treatment. Bortezomib is a key drug used for the treatment of myeloma and AL amyloidosis. We retrospectively investigated the efficacy and toxicity of bortezomib-based chemotherapy in patients with newly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hur, Joon Young, Yoon, Sang Eun, Kim, Darae, Choi, Jin-oh, Min, Ju-Hong, Kim, Byung Jun, Kim, Jung Sun, Lee, Jung Eun, Choi, Joon Young, Jeon, Eun-Seok, Kim, Seok Jin, Kim, Kihyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721454/ https://www.ncbi.nlm.nih.gov/pubmed/34801989 http://dx.doi.org/10.5045/br.2021.2021121

Ejemplares similares

Untangling Amyloidosis: Recent Advances in Cardiac Amyloidosis
por: Kim, Darae, et al.
Publicado: (2020)

Prognostic values of novel biomarkers in patients with AL amyloidosis
por: Kim, Darae, et al.
Publicado: (2019)

Prognostic Implication of Longitudinal Changes of Left Ventricular Global Strain After Chemotherapy in Cardiac Light Chain Amyloidosis
por: Bak, Minjung, et al.
Publicado: (2022)

Corrigendum: Prognostic implication of longitudinal changes of left ventricular global strain after chemotherapy in cardiac light chain amyloidosis
por: Bak, Minjung, et al.
Publicado: (2022)

Clinical and prognostic implications of capillary density in patients with cardiac light chain amyloidosis
por: Kim, Darae, et al.
Publicado: (2021)

(99m)Tc-DPD scintigraphy and SPECT/CT in patients with AL and ATTR type amyloidosis: Potential clinical implications
por: Lee, Joohee, et al.
Publicado: (2020)

A Novel Transthyretin Gene Mutation in Hereditary Transthyretin Amyloidosis: A Case Series of Met13dup Patients
por: Jeon, Kina, et al.
Publicado: (2023)

Associations of Electrocardiographic Parameters with Left Ventricular Longitudinal Strain and Prognosis in Cardiac Light Chain Amyloidosis
por: Kim, Darae, et al.
Publicado: (2019)

Direct comparison of diagnostic and clinical values between Tc-99 m DPD and Tc-99 m PYP scintigraphy in patients with cardiac amyloidosis
por: Park, Yong-Jin, et al.
Publicado: (2023)

Early Response to Bortezomib Combined Chemotherapy Can Help Predict Survival in Patients with Multiple Myeloma Who Are Ineligible for Stem Cell Transplantation
por: Lee, Ho Sup, et al.
Publicado: (2013)

Incidence, Cause of Death, and Survival of Amyloidosis in Korea: A Retrospective Population-Based Study
por: Jang, Shin Yi, et al.
Publicado: (2021)

A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma
por: Kim, Min Kyoung, et al.
Publicado: (2017)

Characteristics of South Korean Patients with Hereditary Transthyretin Amyloidosis
por: Choi, Kyomin, et al.
Publicado: (2018)

Bortezomib and melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma
por: Lee, Se Ryeon, et al.
Publicado: (2010)

Clinical features and outcomes of systemic amyloidosis with gastrointestinal involvement: a single-center experience
por: Lim, A Young, et al.
Publicado: (2015)

Looking into a Whole Picture: Ventricular Vascular Coupling-Refining Cardiovascular Risk Stratification in Patients with Obstructive Sleep Apnea
por: Kim, Darae, et al.
Publicado: (2020)

(18)F-FDG PET/CT in Primary AL Hepatic Amyloidosis Associated with Multiple Myeloma
por: Son, Youn Mi, et al.
Publicado: (2011)

Relationship between bortezomib-containing regimens and the incidence of tuberculosis in patients with myeloma
por: Kim, Kihyun, et al.
Publicado: (2013)

Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA
por: Suzuki, Kenshi, et al.
Publicado: (2023)

Oral Maintenance Chemotherapy with 6-Mercaptopurine and Methotrexate in Patients with Acute Myeloid Leukemia Ineligible for Transplantation
por: Choi, Yong Won, et al.
Publicado: (2015)

Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-1801 study)
por: Song, Ga-Young, et al.
Publicado: (2022)

A Case of Femoral Compressive Neuropathy in AL Amyloidosis
por: Kang, Eun Ha, et al.
Publicado: (2005)

Acquired Factor X Deficiency in Light Chain Amyloidosis: A Report of 2 Korean Cases
por: Ma, Youngeun, et al.
Publicado: (2011)

Immune checkpoint inhibitors in patients with pretreated HodgkinÊs lymphoma: a Korean single-center, retrospective study
por: Hur, Joon Young, et al.
Publicado: (2020)

Comparison of Total Body Irradiation (TBI) Conditioning with Non-TBI for Autologous Stem Cell Transplantation in Newly Diagnosed or Relapsed Mature T- and NK-Cell Non-Hodgkin Lymphoma
por: Maeng, Chi Hoon, et al.
Publicado: (2017)

Semi-quantitative FDG parameters predict survival in multiple myeloma patients without autologous stem cell transplantation
por: Lee, Hyunjong, et al.
Publicado: (2023)

The Korean Organ Transplant Registry (KOTRY): Second Official Adult Heart Transplant Report
por: Kim, Darae, et al.
Publicado: (2019)

Response of Bortezomib Chemotherapy in Hepatic Amyloidosis
por: Hasan, Syed M., et al.
Publicado: (2018)

Changes in Osteoblastic Activity in Patient Who Received Bortezomib as Second Line Treatment for Plasma Cell Myeloma: A Prospective Multicenter Study
por: Eom, Ki-Seong, et al.
Publicado: (2014)

Real-world experiences of CNS-directed chemotherapy followed by autologous stem cell transplantation for secondary CNS involvement in relapsed or refractory diffuse large B-cell lymphoma
por: Jeong, Sun Young, et al.
Publicado: (2023)

The impact of preoperative kidney replacement therapy on kidney outcome and survival in patients with left ventricular assist device
por: Jeon, Hojin, et al.
Publicado: (2023)

Prognostic Value of Axillary Lymph Node Texture Parameters Measured by Pretreatment (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Locally Advanced Breast Cancer with Neoadjuvant Chemotherapy
por: Hwang, Jae Pil, et al.
Publicado: (2022)

Bortezomib inhibits the survival and proliferation of bone marrow stromal cells
por: Kim, Ha-Yon, et al.
Publicado: (2015)

Bortezomib Reduces Neointimal Hyperplasia in a Rat Carotid Artery Injury Model
por: Kim, Ki-Seok, et al.
Publicado: (2013)

Clinical outcome in patients with end-stage heart failure who underwent continuous-flow left ventricular assist devices in a single center
por: Park, Yoonjee, et al.
Publicado: (2022)

Cyclophosphamide, Bortezomib, and Dexamethasone Consolidation in Patients with Multiple Myeloma after Stem Cell Transplantation: The KMM130 Study
por: Jung, Jongheon, et al.
Publicado: (2023)

Cardiac Amyloidosis Determines the Prognosis of Systemic Amyloidosis; Roles and Responsibilities of Cardiologist
por: Lee, Ga Yeon, et al.
Publicado: (2013)

Clinical Characteristics and Prognostic Factors of Lung Cancer in Korea: A Pilot Study of Data from the Korean Nationwide Lung Cancer Registry
por: Kim, Ho Cheol, et al.
Publicado: (2019)

Erratum: Clinical Characteristics and Prognostic Factors of Lung Cancer in Korea: A Pilot Study of Data from the Korean Nationwide Lung Cancer Registry
por: Kim, Ho Cheol, et al.
Publicado: (2019)

Poor prognostic significance of Mycobacterium tuberculosis infection during bortezomib-containing chemotherapy in patients with multiple myeloma
por: Ahn, Jae-Sook, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5om285pubscpt54jdjupiurmtq